BioVersys

Manufacturing · Switzerland · 11-50 Employees

View Company Info for Free

Overview

Headquarters

C/o Technologiepark Hochbergerstrasse 60...

Phone Number

+41 615515120

Website

www.bioversys.com

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1

About BioVersys

BioVersys is a Swiss pharmaceutical company dedicated to combating antimicrobial resistance (AMR) and improving patient outcomes through innovative research and development. The company focuses on creating small molecules that target drug-resistant infections, including tuberculosis and serious hospital infections. With a rich pipeline of novel therapies, BioVersys aims to address unmet medical needs and tackle the growing threat of antibiotic-resistant germs. Their mission is to save lives and enhance global healthcare systems in the face of this silent pandemic.Explore more
BioVersys's Social MediaPopular SearchesBioVersys AGBioVersysBioVersys’sSIC Code 28,283NAICS Code 32,325Show more

Is BioVersys your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Last 7 days

Check if BioVersys has recently received funding, and reach out quickly before it becomes old news!

Product Launch: Get notified when BioVersys launches new products

Click to see if BioVersys had a recent Job posting/layoffs

Congratulate Masked Content for being promoted to Masked Content at BioVersys

Earning: See what the market has to say on BioVersys recently announced quarterly report

BioVersys, which may be a good buyer, showed buying intent in Masked Content Topic

Funding: Get notified immidiatlly once BioVersys has new funding data

Check out if BioVersys is spiking on competitors!

Website visits: Recent activity has been detected on your website

Competitive Alert! Recent activity has been detected by your competitor Masked Content

Recommended Actions

Reach out to Masked Content who joined BioVersys as Masked Content

Find 2 more new buyers

Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

BioVersys is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

BioVersys is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BioVersys.

BioVersys financials insights

Gather financial insights about BioVersys, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2017

Series A

$5M

2020

Series B

$20.9M

2024

Series C

$47.5M

See All BioVersys's Financials Insights

BioVersys Tech Stack

A closer look at the technologies used by BioVersys

Microsoft Dynamics CRM

By

Microsoft
Microsoft 365

By

Microsoft
Google Workspace

By

Google
Dropbox

By

Dropbox
See more technologies

Most Recent Scoops

Person-Based
Marc Gitzinger discusses the company antibiotics pipeline momentum, including the advancement of BV100 into Phase III trials and progress on the GSK-partnered tuberculosis asset.
Medical Research, Pharmaceuticals
Partnership
BioVersys has entered into a collaboration and license agreement with Hackensack Meridian Health to strengthen its ansamycin platform and nontuberculous mycobacteria research. The partnership aims to advance development in these therapeutic areas through combined expertise and resources.
Partnership, Business Development, Intellectual Property, Medical Research, Pharmaceuticals, Healthcare Technology
Project
BioVersys is sponsoring an interventional clinical trial focused on phase 2a trial of alpibectir plus ethionamide for tuberculosis meningitis. The trial began on March 2026 with the expected completion date of October 2028. The trial is currently in phase two.
Laboratory Operations, Medical Research, Clinical Operations
Hiring Plans
BioVersys has more open roles in Medical & Health than it has had at any time in the past 12 months. Areas of expertise include: Anesthesiology, Infectious Diseases, Early Clinical Development, Clinical System Operations, Medical Monitoring, Internal Medicine, and Biotechnology.
Hiring Plans
Hiring Plans
Hiring Plans
See more scoops

Top Manufacturing Companies

Top companies in Canada by revenue

PharmaPrinciples Intl
Delmar Chemicals
BLES Biochemicals
Ayurcann
Seaford Pharmaceuticals
View Full List

Top companies in Australia by revenue

Circadin Australia
Mucpharm
HCP Management Operations
ACPHARM QUEENSLAND
Solagran
View Full List

Top companies in New Zealand by revenue

Argenta
Greenfern Industries
logo for NeilMed Pharmaceuticals New Zealand
NeilMed Pharmaceuticals New Zealand
Advil
Curonz
View Full List
See more top companies

Frequently Asked Questions Regarding BioVersys

What is BioVersys's official website?
BioVersys's official website is www.bioversys.com What is BioVersys's Revenue?
BioVersys's revenue is <$5 Million What is BioVersys's SIC code?
BioVersys's SIC: 28,283 What is BioVersys's NAICS code?
BioVersys's NAICS: 32,325 How many employees does BioVersys have?
BioVersys has 11-50 employees What industry does BioVersys belong to?
BioVersys is in the industry of: Manufacturing, Pharmaceuticals, Business Services What technology does BioVersys use?
Some of the popular technologies that BioVersys uses are: Microsoft Dynamics CRM, Microsoft 365, Google Workspace, Dropbox How do I contact BioVersys?
BioVersys contact info: Phone number: +41 615515120 Website: www.bioversys.com What does BioVersys do?

BioVersys is a Swiss pharmaceutical company dedicated to combating antimicrobial resistance (AMR) and improving patient outcomes through innovative research and development. The company focuses on creating small molecules that target drug-resistant infections, including tuberculosis and serious hospital infections. With a rich pipeline of novel the... rapies, BioVersys aims to address unmet medical needs and tackle the growing threat of antibiotic-resistant germs. Their mission is to save lives and enhance global healthcare systems in the face of this silent pandemic.Read More

 What are BioVersys social media links?
BioVersys Linkedin page BioVersys Twitter page Who invested in BioVersys?
BioVersys has 4 investors including The AMR Action Fund and GSK. Is BioVersys a public company?
BioVersys is private company therefore does not currently have an official ticker symbol
See more information about BioVersys

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.

Test Drive ZoomInfo's Directories

Browse Directories

Most Searched Industries

Construction Law Firms & Legal Services Business Services Finance Manufacturing Agriculture Software Accounting & Accounting Services Retail Healthcare Energy, Utilities & Waste Treatment Telecommunications Transportation Real Estate
People SearchCompany Search